1: Li L, Zeng P, Yu L, Yang J, Man J, Zhou L, Zhao L. Salinomycin sodium exerts anti diffuse large B-cell lymphoma activity through inhibition of LRP6-mediated Wnt/β-catenin and mTORC1 signaling. Leuk Lymphoma. 2023 Jun;64(6):1151-1160. doi: 10.1080/10428194.2023.2202291. Epub 2023 Apr 24. Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Kolar B, Kouba M, López-Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Villa RE, Wallace RJ, Wester P, Brantom P, Halle I, van Beelen P, Holczknecht O, Vettori MV, Gropp J. Safety and efficacy of Sacox® microGranulate (salinomycin sodium) for rabbits for fattening. EFSA J. 2018 Mar 22;16(3):e05209. doi: 10.2903/j.efsa.2018.5209. 3: Zhou J, Sun J, Chen H, Peng Q. Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles. Int J Oncol. 2018 Sep;53(3):1289-1300. doi: 10.3892/ijo.2018.4474. Epub 2018 Jul 6. 129(48):14989-95. doi: 10.1021/ja075024l. Epub 2007 Nov 10. 7(18):26580-92. doi: 10.18632/oncotarget.8555.
合成参考文献
参考文献:10.1124/mol.119.115964 摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964.